Global In-vitro Diagnostics Enzymes Market Size & Outlook
Global in-vitro diagnostics enzymes market, 2018-2030 (US$M)
Global in-vitro diagnostics enzymes market highlights
- The global in-vitro diagnostics enzymes market generated a revenue of USD 1,702.5 million in 2024 and is expected to reach USD 3,047.3 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 10.2% by 2030.
- In terms of segment, polymerase & transcriptase accounted for a revenue of USD 726.2 million in 2024.
- Proteases is the most lucrative enzyme segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 1,702.5 million |
| Market revenue in 2030 | USD 3,047.3 million |
| Growth rate | 10.2% (CAGR from 2025 to 2030) |
| Largest segment | Polymerase & transcriptase |
| Fastest growing segment | Proteases |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Proteases, Polymerase & Transcriptase, Ribonuclease |
Other key industry trends
- In terms of revenue, the North America accounted for 45.7% of the global in-vitro diagnostics enzymes market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 140.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Diagnostics Enzymes Market Scope
In-vitro Diagnostics Enzymes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global in-vitro diagnostics enzymes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro diagnostics enzymes market will help companies and investors design strategic landscapes.
Polymerase & transcriptase was the largest segment with a revenue share of 42.65% in 2024. Horizon Databook has segmented the Global in-vitro diagnostics enzymes market based on proteases, polymerase & transcriptase, ribonuclease covering the revenue growth of each sub-segment from 2018 to 2030.
- Global In-vitro Diagnostics Enzymes Enzyme Outlook (Revenue, USD Million, 2018-2030)
- Proteases
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Global In-vitro Diagnostics Enzymes Disease Type Outlook (Revenue, USD Million, 2018-2030)
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Global In-vitro Diagnostics Enzymes Technology Outlook (Revenue, USD Million, 2018-2030)
- Histology Assays
- Clinical Chemistry
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Global In-vitro Diagnostics Enzymes End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
Reasons to subscribe to Global in-vitro diagnostics enzymes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global in-vitro diagnostics enzymes market databook
-
Our clientele includes a mix of in-vitro diagnostics enzymes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global in-vitro diagnostics enzymes market, including forecasts for subscribers. This global databook contains high-level insights into Global in-vitro diagnostics enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global in vitro diagnostics enzymes market size, by regions, 2018-2030 (US$M)
Top 10 countries: In vitro diagnostics enzymes market size, 2024 (US$M)
Global in vitro diagnostics enzymes market share, by enzyme, 2024 & 2030 (%, US$M)
In-vitro diagnostics enzymes market: Opportunity assessment by country
Global in-vitro diagnostics enzymes market, by region, 2024 (US$M)
| Enzyme | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 512.4 | 550.3 | 845.6 | 1,251.2 | 1,099.4 | 754.5 | 778.6 | 859.6 | 949.2 | 1,048.0 | 1,156.5 | 1,275.3 | 1,405.1 | 10.3% |
| Europe | 298.1 | 317.3 | 483.2 | 708.4 | 616.8 | 419.4 | 428.8 | 469.0 | 513.1 | 561.1 | 613.3 | 669.9 | 731.0 | 9.3% |
| Asia Pacific | 233.8 | 253.5 | 393.4 | 587.9 | 521.8 | 361.7 | 377.1 | 420.5 | 469.2 | 523.3 | 583.5 | 650.3 | 724.0 | 11.5% |
| Latin America | 50.9 | 53.7 | 81.2 | 118.0 | 101.9 | 68.7 | 69.6 | 75.5 | 81.9 | 88.8 | 96.2 | 104.2 | 112.7 | 8.3% |
| MEA | 37.0 | 38.8 | 58.1 | 83.9 | 71.9 | 48.1 | 48.4 | 52.1 | 56.0 | 60.2 | 64.7 | 69.5 | 74.6 | 7.5% |
| Overall | 1,132.2 | 1,213.7 | 1,861.5 | 2,749.4 | 2,411.7 | 1,652.3 | 1,702.5 | 1,876.7 | 2,069.4 | 2,281.5 | 2,514.3 | 2,769.1 | 3,047.3 | 10.2% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
